Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSQN.L Regulatory News (SQN)

  • There is currently no data for SQN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Anaerobic Digestion Assets

20 Jan 2020 08:26

RNS Number : 2893A
SQN Asset Finance Income Fund Ltd
20 January 2020
 

20 January 2020

 

SQN Asset Finance Income Fund Limited

 

Anaerobic Digestion Assets

 

SQN Asset Finance Income Fund Limited (the "Company") has invested in a total of 15 Anaerobic Digestion ("AD") plants since its launch. Four have subsequently been exited profitably and 11 remain in the ordinary share portfolio.

 

At the time of the publication of the Annual Report and Accounts for the year ended 30 June 2019, which were released on 30 September 2019, the Company reported all of the AD plants had completed construction and that six were in the ramp-up phase which often involves continuous refinement until the plants reach optimum output. As reported in the results, this process has proven to take longer than anticipated and occasionally requires additional capital which can affect the overall economics of the investments. This led the Company to make an impairment at that time of £3.2 million across two of these AD plants.  

 

In preparation for the review of the interim accounts for the six months ended 31 December 2019, the Company is undertaking a review of the models and projections supporting the carrying values of the AD plants. Three of the AD plants have not yet reached targeted operational capacity. A further three AD plants are performing at or above the targeted operational capacity but feedstock costs have been higher than originally anticipated.

 

As a result, the Investment Manager has undertaken an assessment of the valuation of these assets. Given the large number of variables and the high degree of sensitivity of each of those variables when modelled over the more than 20 year lives of the assets, the range of potential values is large. If the range of values were to be accepted and deemed appropriate for purposes of the interim accounts, a potential impairment of between 4.6 pence to 13.2 pence per ordinary share would have to be recorded. Given the wide range of potential values, and in the interests of prudent risk management, the Board intends to appoint a third-party valuer to provide an independent assessment of the valuation of these assets, which will then be reflected in the 31 December 2019 net asset value ("NAV"). The six assets, in aggregate, had a valuation of £127.7 million, as at 30 November 2019.

 

The C share portfolio has no exposure to AD assets.

 

In light of this ongoing assessment, the publication of the 31 December 2019 NAV for the ordinary shares is expected to be delayed and a further update will be released as soon as possible. The 31 December 2019 NAV for the C shares is expected to be announced later this week.

 

The Investment Manager will continue to work with the asset operators to achieve optimisation of each of the AD plants with the intention of monetising these assets in due course, together with the five AD plants operating in-line with expectations. It should be noted that the four AD plants that have been exited to date have achieved yields of between 11% and 20%, the highest return being on an investment that went into default and required a complicated workout.

 

The Company has a triennial continuation vote, with the next vote to be held at its AGM this year and the Board intends to consult with shareholders in due course.

 

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

 

LEI: 2138007S3YRY3IUU4W39

 

 

For further information please contact:

 

SQN Capital Management, LLC

Jeremiah Silkowski

Neil Roberts

 

01932 575 888

Winterflood Securities Limited

020 3100 0000

Neil Langford

Chris Mills

 

Buchanan

Charles Ryland

Henry Wilson

020 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZZGZMRGDGGZG
Date   Source Headline
17th Jul 20202:58 pmRNSChange of Name
16th Jul 202012:38 pmRNSResult of EGM and Class Meetings
8th Jul 20207:00 amRNSInvestment Update
24th Jun 20207:00 amRNSNet Asset Value(s)
17th Jun 20203:02 pmRNSHolding(s) in Company
16th Jun 20207:00 amRNSContinuation Vote and Publication of Circular
8th Jun 20207:00 amRNSAppointment of Investment Manager
22nd May 20207:00 amRNSNet Asset Value(s)
5th May 202012:03 pmRNSDisclosure of rights attached to listed securities
30th Apr 20207:00 amRNSConclusion of Strategic Review & Change of Manager
24th Apr 20202:23 pmRNSMonthly Net Asset Value and Covid-19 update
14th Apr 202011:35 amRNSHolding(s) in Company
6th Apr 20204:42 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 20203:21 pmRNSHalf-Yearly Report
1st Apr 20208:51 amRNSHalf-year Report - Delay in publication
31st Mar 20202:13 pmRNSJanuary and February Net Asset Values
31st Mar 20201:01 pmRNSOutcome of KPMG Review & Release of December NAV
24th Mar 20207:00 amRNSMonthly Net Asset Value and Dividend
18th Mar 202011:32 amRNSUpdate on Dividends
18th Mar 20207:00 amRNSForeign Exchange Hedging
5th Mar 20207:00 amRNSConclusion of a further Anaerobic Digestion plant
25th Feb 20207:00 amRNSBoard Responsibilities
21st Feb 20207:00 amRNSNet Asset Value and Dividend
13th Feb 20207:00 amRNSUpdate on AD Plant Valuation & Strategic Review
12th Feb 20207:00 amRNSMarket Update
5th Feb 202011:25 amRNSHolding(s) in Company
28th Jan 202010:08 amRNSStrategic Review Update
27th Jan 202011:40 amRNSHolding(s) in Company
24th Jan 20207:00 amRNSMonthly Net Asset Value and Dividend
24th Jan 20207:00 amRNSStrategic Review
20th Jan 20208:26 amRNSAnaerobic Digestion Assets
2nd Jan 202010:58 amRNSTotal Voting Rights
20th Dec 20197:00 amRNSNet Asset Value and Dividend
11th Dec 20195:43 pmRNSTransaction in Own Shares
9th Dec 20194:46 pmRNSTransaction in Own Shares
5th Dec 20193:51 pmRNSTransaction in Own Shares (Replacement)
4th Dec 20196:00 pmRNSDirectorate Change
4th Dec 20197:30 amRNSTransaction in Own Shares
2nd Dec 20195:01 pmRNSTransaction in Own Shares
28th Nov 20195:30 pmRNSTransaction in Own Shares
22nd Nov 20197:00 amRNSNet Asset Value and Dividend
21st Nov 20194:21 pmRNSResult of AGM and Class Meetings
28th Oct 20194:02 pmRNSNotice of AGM and Class Meetings
28th Oct 20197:00 amRNSMonthly NAV and Dividend
25th Oct 20192:28 pmRNSHolding(s) in Company
8th Oct 20194:38 pmRNSAnnual Financial Report (Replacement)
2nd Oct 201912:01 pmRNSNet Asset Value and Dividend (replacment)
30th Sep 20197:01 amRNSAnnual Financial Report
30th Sep 20197:00 amRNSNet Asset Value and Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.